Company

News

WEBINAR: Assessing Cognitive Safety of Drugs in Clinical Development

Posted on 15 April 2016

Dr Kenton Zavitz, Director of Clinical Affairs will be joining Inventiv Health in their webinar on Assessing Cognitive Safety of Drugs in Clinical Development. 

Read on

First showing of groundbreaking mental health wearable Cognition Kitâ„¢ at Neurotech 2016

Posted on 6 April 2016

Cambridge Cognition and Ctrl Group Limited are presenting the first prototype of a ground-breaking new software application to improve the understanding, diagnosis and treatment of mental health ahead of schedule on April 7 at the Neurotech Investing and Partnering Conference in Boston, MA

Read on

Schizophrenia International Research Society 2016

Posted on 31 March 2016

The 5th Biennial Schizophrenia International Research Society Conference will take place 2-6 April 2016 in Florence, Italy at the Firenze Fiera Congress Center.

Read on

BioMarin CANTAB sub study shows cognitive improvement favouring Pegvaliase for treatment of PKU

Posted on 23 March 2016

BioMarin announced on 21st March 2016 that the Phase 3 PRISM-2 study of pegvaliase met the primary endpoint of change in blood Phe compared with placebo (p<0.0001) in preliminary results.

Read on